P. S. Jones

Novel Approaches to the Treatment of Hepatitis C Virus Infection

F. Wilson, B. Dymock, P. S. Jones, 2000, Antiviral chemistry & chemotherapy.

Synthesis of tetrasubstituted bicyclo[3.2.1]octenes as potential inhibitors of influenza virus sialidase.

G. Hardy, R. Bethell, R. Upton, 1999, Bioorganic & medicinal chemistry letters.

Solid phase synthesis of aminoboronic acids: potent inhibitors of the hepatitis C virus NS3 proteinase.

F. Wilson, R. Dunsdon, S. Jordan, 2000, Bioorganic & medicinal chemistry letters.

The Design and Synthesis of Potent Inhibitors of Hepatitis C Virus NS3–4A Proteinase

N. Jennings, F. Wilson, M. Carr, 1999, Antiviral chemistry & chemotherapy.

6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors.

Joost C. M. Uitdehaag, X. Fradera, Z. Rankovic, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-Guanidino-Neu5Ac2en (Zanamivir) modified in the glycerol side-chain.

D. M. Andrews, P. C. Cherry, S. Swanson, 1999, European journal of medicinal chemistry.

Inhibitors of cholesterol biosynthesis. 1. 3,5-Dihydroxy-7-(N-imidazolyl)-6-heptenoates and -heptanoates, a novel series of HMG-CoA reductase inhibitors.

C. Chan, G. Inglis, B. E. Kirk, 1993, Journal of medicinal chemistry.

Mutagenesis Studies of Interleukin-8 IDENTIFICATION OF A SECOND EPITOPE INVOLVED IN RECEPTOR BINDING*

N. Borkakoti, S. Kirtland, G. Williams, 1996 .

Quantitative measurements of edge-to-face aromatic interactions by using chemical double-mutant cycles.

C. Hunter, D. Livingstone, J. McCabe, 2001, Chemistry.